Every material Form 8-K Solana Co has filed with the SEC since May 29, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
On September 30, 2026, Solana Company agreed to sell 4,369,356 Class A shares at $3.433 each to a single institutional investor, with warrants for the same number of shares at $3.776. Gross proceeds are expected to be about $15 million, or about $14.3 million net, and the offering is expected to close on or about October 1, 2026. The issuance adds new shares that existing shareholders will share in, and the company plans to use the proceeds to accumulate SOL, buy back stock, and for working capital and other purposes.
4,369,356 Class A shares sold at $3.433 per share, with warrants for up to 4,369,356 shares at $3.776 per share
Gross proceeds about $15 million; net proceeds about $14.3 million; placement agent cash fee of 4.0% of gross proceeds
Shares priced at a 5% premium to net asset value per share; company reported total NAV of $278 million as of September 24, 2026, with SOL at $119
Closing expected on or about October 1, 2026; Clear Street served as exclusive placement agent
Solana Company reported a second-quarter 2026 net loss of $30.3 million, or $0.38 per share, compared with a net loss of $9.8 million in the prior-year quarter. Revenue rose to $2.5 million, mainly from staking on its SOL holdings, but operating expenses reached $35.1 million, including $6.8 million of severance tied to the divestiture of its legacy PoNS medical device business.
Q2 2026 revenue was $2.5 million, almost all staking revenue, versus $43 thousand a year earlier
Q2 2026 net loss was $30.3 million, or $0.38 per share, versus $9.8 million in the prior-year quarter
General and administrative expenses were $11.1 million, including $6.8 million of severance tied to the PoNS divestiture
Total assets were $176.1 million at June 30, 2026, down from $303.9 million at December 31, 2025, and cash was $3.6 million
Solana Company entered into an amended sales agreement with Clear Street LLC and Maxim Group LLC on May 29, 2026, raising the aggregate gross sales price of Class A shares it may sell under its at-the-market offering from $92.8 million to $250 million. The filing states that no sales are obligated and that no assurance is given any shares will be sold, so the change adds capacity for share issuance that could dilute existing shareholders if used.
Offering capacity increased from $92.8 million to $250 million, excluding shares sold under the prior prospectus supplement.
As of May 29, 2026, the company had sold shares for aggregate gross proceeds of $24,657,697.51 under the prior arrangement.
Agents may be paid commissions of up to 3.00% of gross proceeds from each sale.
Cooley LLP issued a legal opinion on the validity of the shares; the agreement was filed as Exhibit 10.1.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Solana Co filing is on SEC EDGAR ↗. 8-K briefs of other companies →